Literature DB >> 28796482

Sensitive, Robust, and Cost-Effective Approach for Tyrosine Phosphoproteome Analysis.

Mingming Dong1,2, Yangyang Bian1,3, Yan Wang1,2, Jing Dong1, Yating Yao1,2, Zhenzhen Deng1,2, Hongqiang Qin1, Hanfa Zou1, Mingliang Ye1.   

Abstract

Albeit much less abundant than Ser/Thr phosphorylation (pSer/pThr), Tyr phosphorylation (pTyr) is considered as a hallmark in cellular signal transduction. However, its analysis at the proteome level remains challenging. The conventional immunopurification (IP) approach using antibodies specific to pTyr sites is known to have low sensitivity, poor reproducibility and high cost. Our recent study indicated that SH2 domain-derived pTyr-superbinder is a good replacement of pTyr antibody for the specific enrichment of pTyr peptides for phosphoproteomics analysis. In this study, we presented an efficient SH2 superbinder based workflow for the sensitive analysis of tyrosine phosphoproteome. This new method can identify 41% more pTyr peptides than the previous method. Its excellent performance was demonstrated by the analysis of a variety of different samples. For the highly tyrosine phosphorylated sample, for example, pervanadate-treated Jurkat T cells, it identified over 1800 high confident pTyr sites from only 2 mg of proteins. For the unstimulated Jurkat cells, where the pTyr events rarely occurred, it identified 343 high confident pTyr sites from 5 mg of proteins, which was 31% more than that obtained by the antibody-based method. For the heterogeneous sample of tissue, it identified 197 high confident pTyr sites from 5 mg protein digest of mouse skeletal muscle. In general, it is a sensitive, robust and cost-effective approach and would have wide applications in the study of the regulatory role of tyrosine phosphorylation in diverse physiological and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28796482     DOI: 10.1021/acs.analchem.7b02078

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  4 in total

1.  Tandem Mass Tag Approach Utilizing Pervanadate BOOST Channels Delivers Deeper Quantitative Characterization of the Tyrosine Phosphoproteome.

Authors:  Xien Yu Chua; Theresa Mensah; Timothy Aballo; Samuel G Mackintosh; Ricky D Edmondson; Arthur R Salomon
Journal:  Mol Cell Proteomics       Date:  2020-02-18       Impact factor: 5.911

2.  (Arg)9-SH2 superbinder: a novel promising anticancer therapy to melanoma by blocking phosphotyrosine signaling.

Authors:  An-Dong Liu; Hui Xu; Ya-Nan Gao; Dan-Ni Luo; Zhao-Feng Li; Courtney Voss; Shawn S C Li; Xuan Cao
Journal:  J Exp Clin Cancer Res       Date:  2018-07-05

3.  Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.

Authors:  An-Dong Liu; Jie Zhou; Xiao-Yang Bi; Guo-Qing Hou; Shawn Shun-Cheng Li; Qing Chen; Hui Xu; Xuan Cao
Journal:  Clin Transl Med       Date:  2021-03

4.  Motif-centric phosphoproteomics to target kinase-mediated signaling pathways.

Authors:  Chia-Feng Tsai; Kosuke Ogata; Naoyuki Sugiyama; Yasushi Ishihama
Journal:  Cell Rep Methods       Date:  2022-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.